Increased platelet reactivity in patients given Orbofiban after an acute coronary syndrome:: An OPUS-TIMI 16 substudy

被引：75
|
作者：
Holmes, MB
Sobel, BE
Cannon, CP
Schneider, DJ
机构：
[1] Univ Vermont, Coll Med, Cardiol Unit, Dept Med, Burlington, VT 05401 USA
[2] Brigham & Womens Hosp, Cambridge, MA USA
[3] Harvard Univ, Sch Med, Cambridge, MA 02138 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2000年 / 85卷 / 04期
关键词：
D O I：
10.1016/S0002-9149(99)00778-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The results of the present study underscore the potential value of the use of sensitive assays of specific aspects of platelet function for identifying and quantifying changes in platelet reactivity after initiation of therapy with antiplatelet agents. Implementation of such assays could contribute to optimal design and performance of clinical trials of antiplatelet agents as well as treatment of patients with acute coronary syndromes.
引用
收藏
页码：491 / 493
页数：3
相关论文
共 50 条
  • [1] Effect of beta-blockers on mortality in patients with acute coronary syndromes: OPUS-TIMI 16 substudy.
    Kovar, D
    Bentley, JH
    Charlesworth, A
    Rogers, WJ
    CIRCULATION, 2001, 104 (17) : 725 - 725
  • [2] Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study
    Smith, EE
    Cannon, CP
    Murphy, S
    Feske, SK
    Schwamm, LH
    AMERICAN HEART JOURNAL, 2006, 151 (02) : 338 - 344
  • [3] Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial
    Cannon, CP
    McCabe, CH
    Wilcox, RG
    Langer, A
    Caspi, A
    Berink, P
    Lopez-Sendon, J
    Toman, J
    Charlesworth, A
    Anders, RJ
    Alexander, JC
    Skene, A
    Braunwald, E
    CIRCULATION, 2000, 102 (02) : 149 - 156
  • [4] Increased expression of platelet β-selectin in patients treated with oral orbofiban in the OPUS TIMI 16 study
    Casey, M
    Fornari, C
    Bozovich, GE
    Varela, MLI
    Mautner, B
    Cannon, CP
    CIRCULATION, 1999, 100 (18) : 681 - 681
  • [5] Oral IIb/IIIa inhibition and revascularization: Preliminary results from OPUS-TIMI 16 (Orbofiban in patients with unstable coronary syndromes)
    Cannon, CP
    McCabe, CH
    Wilcox, RG
    Charlesworth, A
    Foxley, A
    Anders, RJ
    Alexander, JC
    Skene, AM
    Braunwald, E
    CIRCULATION, 1999, 100 (18) : 498 - 498
  • [6] Increased platelet reactivity in the initial 14 days after an acute coronary syndrome is not attenuated by orbofiban
    Holmes, MB
    Sobel, BE
    Schneider, DJ
    CIRCULATION, 1999, 100 (18) : 431 - 431
  • [7] Prognostic Evaluation of Catalytic Iron in Patients with Acute Coronary Syndromes: Observations from OPUS-TIMI 16
    Steen, Dylan L.
    Cannon, Christopher P.
    Lele, Suhas
    Rajapurkar, Mohan
    Mukhopadhyay, Banibrata
    Scirica, Benjamin M.
    Morrow, David A.
    CIRCULATION, 2012, 126 (21)
  • [8] Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: Analysis of the orbofiban in patients with unstable coronary syndromes-thrombolysis in myocardial infarction 16 (OPUS-TIMI 16) trial
    Atar, Shaul
    Cannon, Christopher P.
    Murphy, Sabina A.
    Rosanio, Salvatore
    Uretsky, Barry F.
    Birnbaum, Yochai
    AMERICAN HEART JOURNAL, 2006, 151 (05) : 976.e1 - 976.e6
  • [9] Association between blood glucose and long term mortality in patients with acute coronary syndromes in the OPUS-TIMI 16 trial
    Bhadriraju, S
    Cannon, CP
    DeFranco, AC
    Barber, K
    Bhadriraju, P
    Gibson, CM
    Morrow, DA
    McCabe, CH
    Braunwald, E
    CIRCULATION, 2003, 108 (17) : 313 - 313
  • [10] Early statin therapy is associated with markedly lower mortality in patients with acute coronary syndromes: Observations from OPUS-TIMI 16
    Cannon, CP
    McCabe, CH
    Bentley, J
    Braunwald, E
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 334S - 334S
12345